ECG vs SpO2: understanding two different smartwatch health sensors
The article distinguishes ECG, which records the heart’s electrical activity, from SpO2, which estimates blood oxygen saturation using optical sensors. A smartwatch ECG is typically a single-lead or limited-lead measurement and does not match the diagnostic scope of a clinical ECG. The guide stresses that these readings serve different purposes and should not be treated as an overall health score.
A smartwatch ECG captures the heart’s electrical signals through contacts on the device and body. Usually, the wearer touches an opposite-hand finger to a sensor, completing a circuit. This setup yields a single-lead or limited recording, so it can flag some rhythm patterns but cannot replicate a hospital ECG’s broader diagnostic reach.
SpO2, by contrast, uses optical sensing to estimate peripheral oxygen saturation—the share of hemoglobin carrying oxygen. It appears as a percentage, such as 97%, and is not the same as heart rate. Both metrics answer different questions and should not be combined into a general wellness score.
Wider adoption of these sensors may affect everyday users, athletes, older adults, and clinicians. People could gain earlier awareness of irregular rhythms or low oxygen estimates, prompting conversations with professionals. Yet false reassurance or anxiety may arise if readings are misunderstood as complete health assessments. Manufacturers and regulators may face pressure to clarify limits, while users may need clearer guidance on when to seek care.